Porsolt - Preclinical CRO Email Format
Research ServicesPays de la Loire, France51-200 Employees
Porsolt is a long-established preclinical contract research organization focused on supporting drug development through in vitro, ex vivo, and in vivo studies across multiple physiopathological models. The company provides tailored scientific guidance and customized solutions to advance preclinical development and safety evaluation, offering GLP-compliant services from screening through pre-Phase 1 regulatory studies. Its work encompasses histology, biomarkers, and specialized procedures to aid therapeutic discovery, including assessment of arrhythmogenic risk and potential for abuse or dependence, addressing the needs of researchers and pharmaceutical clients seeking comprehensive preclinical data. Based in Laval, France, the organization serves the research services sector with a recognized international reputation for its breadth of expertise across more than ten therapeutic areas, supported by a physician-scientist approach that emphasizes science-driven, tailored solutions. The firm operates within the preclinical CRO landscape, positioning itself as a provider capable of delivering end-to-end safety and efficacy evaluation under GLP standards for drug candidates.